Project Grant R43HL174372
Award Date
9/1/24
Completion Date
2/28/25
Dollars Obligated
$309K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Spartanburg, SC 29302, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is funding the development and testing of a novel wearable device to continuously and accurately measure blood loss for postpartum hemorrhage (PPH) prevention. The $639,165 award, spanning May 2025 to February 2030, supports research at Washington University to design a light-based sensor that can estimate cardiovascular parameters and...
This $1,918,854 Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 Child Health and Human Development Extramural Research program supports a multi-site, stepped-wedge randomized rollout trial to study the implementation and effectiveness of a Cesarean section risk calculator in diverse labor units across the United States. The study aims to evaluate the calculator's impact on reducing Cesarean delivery rates and maternal morbidity,...
This Project Grant award of $304,452 from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop a minimally invasive intrauterine labor augmentation system (ILAS) to directly increase labor forces and relieve uterine muscle demand during childbirth. The project objectives are to further develop the system's catheter-balloon component for safe prolonged intrauterine use, finalize the configuration and pleating pattern, and...
The National Institute of Child Health and Human Development (NICHD) awarded Noma AI, Inc. a $305,292 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to develop a real-time, automated, AI-powered maternal hemorrhage risk assessment platform. The platform aims to improve the prediction and management of maternal hemorrhage, a leading cause of maternal mortality and morbidity, particularly among Black mothers who face up to four times higher risk. The project...
The National Heart, Lung, and Blood Institute (NHLBI), through the Cardiovascular Diseases Research (CFDA 93.837) federal grant program, awarded a $1,249,317 Project Grant to Sanaheal Inc. for the development and validation of a "Hemostatic Bioadhesive Paste for Coagulation-Independent Rapid Control of Bleeding." The objective is to optimize and validate this hemostatic paste to meet FDA regulatory requirements in preparation for a future pivotal clinical trial and commercialization....
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $298,368 to Link Medical LLC to develop a novel device for treating mitral valve regurgitation. The funded project aims to optimize the device design and procedure through bench testing, followed by in vivo feasibility studies. The goal is to create a simpler, more robust, and more effective solution than existing technologies for...
This $2,559,308 Project Grant was awarded on January 14, 2025 by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The grant supports a study examining the impact of severe pre-eclampsia on heart function in a racially diverse cohort of women during and after pregnancy. The study aims to characterize the cardiomyopathic genetic profile of participants and assess the functional impact of specific genetic...
This $437,461 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a novel stabilization catheter device for His pacing lead implantation. The goal is to improve the accuracy and ease of His bundle pacing, an emerging alternative cardiac resynchronization therapy (CRT) for heart failure patients. The project aims to refine a deployable suction-tipped lead...
This federal Project Grant award of $790,738, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to develop and evaluate the Thoraflush, a proactive clot-preventing cardiac chest tube that utilizes dual irrigation technology to maintain drainage patency. The key objectives are to: 1) Optimize the Thoraflush's efficacy in maintaining drainage patency using an in vitro mediastinum blood coagulation model, and...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), part of the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $170,420.00 to New York University School of Medicine to conduct research on improving clinical decision-making for high-risk pregnant patients with hypertensive disorders. The key objectives of the research are to: 1) Compare maternal health outcomes between patients with hypertensive...